| Financial Year |
March 31 2023 |
| Monetary Funds |
840,211,251.92 |
| Held-for-trading Financial Assets |
142,228,165.27 |
| Notes Receivable |
-- |
| Accounts Receivable |
58,225,614.70 |
| Advances to Suppliers |
5,060,066.82 |
| Other Receivables |
12,961,958.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,117,599.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,992,617.25 |
| Total Current Assets |
1,136,184,215.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,551,164,309.89 |
| Investment Properties |
62,423,332.28 |
| Fixed Assetes |
327,785,236.02 |
| Under-construction Projects |
270,606,000.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,950,321.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
417,317.01 |
| Deferred Income Tax Assets |
1,531,555.53 |
| Other Non-Current Assets |
69,773,800.52 |
| Sub-Total of Non-Current Assets |
2,511,654,689.97 |
| Total Assets |
3,647,838,905.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
68,446,313.78 |
| Accounts Received In Advance |
41,094.43 |
| Employee Compensation Payable |
13,205,407.73 |
| Taxes Payable |
11,234,813.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,043,897.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,125,636.46 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
140,693,435.48 |
| Long-term Loans |
89,019,336.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,202,279.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
129,916,513.57 |
| Total Liabilities |
270,609,949.05 |
| Paid-In Capital(Or Share Stock) |
3,115,165,266.00 |
| Capital Surplus |
308,654,480.30 |
| Surplus Reserve |
217,028,368.58 |
| LESS:Treasury Stock |
400,080,656.73 |
| Undistributed Profits |
-95,048,876.20 |
| Minority Stockholder's Interest |
240,962,757.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,136,266,199.42 |
| Owner's Equity（Stockholder's Equity） |
3,377,228,956.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,647,838,905.91 |
